Autocrine growth factor activity was found in supernatants of AKR T-cell lymphoma lines cultured in serum-free medium. This factor was designated leukemia-derived growth factor (LDGF). Active supernatants stimulated the growth of the AKR murine T-cell lymphoma line SL 12, its cloned derivatives, and all other murine T-cell lymphoma lines tested. Growth factor activity in conditioned medium was found to be different from interleukin 2 (IL-2) and several other known growth factors. LDGF was able to stimulate growth of the human leukemia T-cells MOLT4, and the LDGF from MOLT4* cells stimulated the mouse cells. Because mouse Tcell lymphoma lines produce and respond to this factor, it may support the continued proliferation of these cells and could be responsible for their malignant in vivo properties.
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In the T-cell lymphoma of AKR mice, factors responsible for the malignant transformation of thymocyte progenitors and maintenance of the malignant phenotype have not been determined. This disease regularly occurs in old mice and is associated in its development with expression of oncogenic retroviruses in the preleukemic period (1) . Inoculation into newborn mice of oncogenic retroviruses accelerates the onset of this T-cell lymphoma in all mice to age 60-90 days. Recent studies have shown that one of the AKR-derived oncogenic retroviruses, SL33c, has an ecotropic host range and is highly lymphomagenic (2, 3) . It also has changes in the direct repeat region of the long terminal repeat of the provirus, which represent the major difference between this virus and the nononcogenic endogenous retrovirus of AKR, Akvc (4) . Because the direct repeat regions contain enhancer elements (nontranslated portions of DNA that can regulate transcription of cellular and viral DNA), specific viral integration near a cellular gene resulting in the enhanced transcription of its product might be responsible for the malignant phenotypic properties of these lymphoma T cells.
The human T-cell leukemia line MOLT4f has been shown to produce a growth factor in serum-free medium that is not interleukin 2 (IL-2) (5). This finding has led us to investigate if AKR lymphoma T cells produce a similar growth factor. In the case of the mouse, it might represent the gene product stimulated by the specific integration of the lymphomagenic virus as described above. The following studies report our findings demonstrating that AKR lymphoma T cells produce a factor that stimulates their own growth, which was designated leukemia-derived growth factor (LDGF). (6) . The mouse cell lines originally were maintained in RPMI 1640 medium with 10% heat-inactivated fetal bovine serum and later were adapted to growth in serum-free medium as described (7) ; the medium consisted of Iscove's modified Dulbecco's medium with added delipidated serum albumin at 400 ug/ml and transferrin at 1 pg/ml (AT-IMD medium). The human cell lines were maintained in the same serum-free medium. The cell lines were tested for mycoplasma contamination by using the fluorescent Hoechst stain (8) . All lines were mycoplasma negative.
MATERIALS AND METHODS
Collection of Conditioned Medium (CM 
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[3H]Thymidine Uptake. The method used for these experiments is described in ref. 5 . CM heated at 80'C for 5 min was used in these studies.
Sensitivity of Growth Factor Activity to Treatment. Onemilliliter amounts of SL 12.4 cell-conditioned medium with growth-promoting activity were incubated with 100 jig of chymotrypsin (Sigma) at 370C for 30 min. The chymotrypsin was inactivated by addition of 10 ;LM phenylmethylsulfonyl fluoride (Sigma) (8) . The treated CM was tested for activity. Supernatant pools with growth-promoting activity were also heated at 960C for 10 min, 80'C for 5 min, or 560C for 30 min and tested for growth factor activity.
Assays for IL-2 and Epidermal Growth Factor (EGF). IL-2 assay was done with CTLL-2 cells as described (9) . Controls for cell growth in this assay utilized a standard source of human IL-2 that stimulated the CTLL-2 cells. Assays for EGF binding as described by Kawamoto et al. (10) were performed by C. MacLeod (University of California, San Diego).
Burst-Promoting Activity (BPA) Assay. Bone marrow cells were obtained by flushing the femurs of 6-wk-old BDF1 mice with a medium. Cells (105) were plated in 24-well tissue culture plates in 0.25 ml of the medium containing 1% delipidated bovine serum albumin, 10% fetal bovine serum, 2 units of erythropoietin (Toyobo, Osaka, Japan) per ml, 0.88% methylcellulose (Dow), and various concentrations of the test samples. The culture was incubated at 370C in humidified 5% CO2/95% air. At day 8, erythroid bursts were evaluated by the use of an inverted microscope. All assays were done in triplicate.
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Assay. Bone marrow cells from BDF1 mice (5 x 104) were plated in 35-mm culture dishes in 1.0 ml of McCoy's SA medium containing 20% horse serum, 0.88% methylcellulose, and various concentrations of the test samples. In control dishes, L cell conditioned medium of known activity was used as a standard of GM-CSF. At the end of 7 days of incubation at 370C in humidified 5% C02/95% air, colonies of 50 or more cells were counted with an inverted microscope. All assays were done in triplicate.
RESULTS
Evidence for Growth Factor Activity. Seven I-cell lymphoma lines (6 AKR and 1 BALB/c) were studied. They all could be maintained in serum-free AT-IMD medium. The cells grew in suspension culture and were composed of large lymphoid blast cells when examined microscopically. All AKR-derived cell lines produced progressively growing tumors when inoculated intradermally into syngeneic mice. When AKR T-cell lymphoma cell lines passed two times in AT-IMD medium from serum-containing medium were seeded at 104 cells per ml in AT-IMD medium, they did not grow.
The addition of CM from SL 12, SL 12.1, SL 12.3, SL 12.4, SAC 8, and SL 3 cells stimulated their growth in an exponential manner. Fig. 1 represents growth of SL 12 in SL 12.4 CM and is representative of all growth curves obtained with the above cells. All supernatants cross-reacted-i.e., all AKR T-cell lymphoma line supernatants tested demonstrated growth-stimulatory activity for itself or other AKR T-cell lymphomas. Autologous growth stimulatory activity also was found in CM from W-7, a BALB/c-derived T-cell lymphoma line. W-7 CM also stimulated the AKR line SL 12.4. When cells were seeded in numbers greater than 104 per ml, they grew exponentially without added CM, and the addition of CM did not enhance their growth (data not shown). Upon continued passage in AT-IMD medium (cultures split twice a week), the numbers of cells that were able to grow without added CM decreased so that, in some instances, growth occurred when as few as 6 x 103 cells were seeded in the culture wells. Fig. 2 demonstrates the phenomenon of the growth at lower cell numbers in lines grown continuously in AT-IMD medium for 1 month. These cells when seeded at 5
x 103 or 1 x 103 did not grow (data not shown).
CM from the myelomonocytic cell line WEHI 3, which had been adapted to AT-IMD medium, did not stimulate Tcell lymphoma growth and was, in fact, inhibitory to cell growth; this inhibitory activity was demonstrated with lymphoma cells cultured at a threshold level of 104 cells per ml (data not shown) and greater than threshold levels (Fig. 3) . mained as single cells after 7 days. Colony growth was dose dependent, thus showing that single cells could be stimulated to replicate by addition of medium containing growth factor activity. The presence of inhibitory factors was suggested when CM in higher concentration was used in the soft agar assay (Fig. 4A) . Heating of CM at 80'C for 5 min restored maximal growth-promoting activity in a dose-dependent manner. The colony number reached plateau levels at 20% CM (Fig. 4B) [3H]Thymidine Incorporation. This method was used as another assessment of growth stimulatory activity of LDGF. The data in Table 1 show that CM from three cell lines stimu-
Cross-Reaction of Murine Growth Factor Activity and Human LDGF. The human T-cell line MOLT4f has been shown to have LDGF activity (5) . Therefore, the SL 12-derived supernatants were tested on the human cells, and the human cell-derived factor was tested on the mouse cell lines. Fig. 5 illustrates the cross-stimulatory activity of CM from human and murine lymphoma T cells. The mouse factor showed growth stimulation not only of MOLT4f but also of the T-cell 106 Our demonstration of cross-reactivity of LDGF from human and murine T cells indicates that the molecule is highly conserved. Its lack of stimulation of the lymphoma B cells, BJAB, show that it has the same T-cell specificity demonstrated previously with human LDGF (5) .
Other examples of growth factors that may be involved in the proliferation of tumor cells have been described. They are: the transforming growth factors, isolated from solid tumor cell lines (13), the many growth factors for hemopoietic cells, the T-cell growth factor (IL-2) produced by the human T-cell leukemia virus-positive cell lines (14) , and LDGF from the human leukemia T-cell line MOLT4f (5).
We assayed several of these factors in LDGF SL 12-containing CM. We found that transforming growth factors do not play a role in our system. They are known to act via EGF or the EGF receptor (13, 15) , and our cells demonstrated no "25I-labeled EGF binding. The hemopoietic growth factor BPA was found in the SL 12 cell supernatants but not in SL 12.1, 12.3, and SL 12.4 supernatants. Also, GM-CSA activity was present in SL 12 cell CM and not in CM of SL 12.1, SL 12.3, and SL 12.4. These results suggest that BPA and GM-CSA are not responsible for the growth stimulation observed. These findings, however, are the first description of BPA activity production by a murine T-cell line.
The inhibitory activity of the WEHI 3 CM for BPA as well as for the growth stimulation of lymphoma T cells suggests that this cell line, when grown in serum-free medium, produces a nonspecific inhibitor. Such inhibitors have been described when cells are cultured in serum-free conditions (16) .
It recently has been shown (17) that some human T-cell leukemia virus-containing T-cell leukemia lines do not maintain their continuous growth through IL-2 stimulation (17). Therefore, IL-2 production is not the only mechanism for growth stimulation in these cells. Since all human T-cell leukemia virus-transformed cells have IL-2 receptors, a virusmediated induction of IL-2 receptors could be the mechanism needed to maintain abnormal growth in this system (18) . IL-2 is not a factor in our studies because such activity was absent from CM-containing LDGF activity. Many malignant lymphoid T-cell lines do not produce (5, 15, 19) or respond (5, 19) to IL-2. These cell lines may produce and utilize different (non-IL-2) growth factors. An example of such a factor is the human LDGF (5). It should be noted here that LDGF differs from IL-2 in its species cross-reactivityi.e., human IL-2 "drives" murine T-cell growth but murine IL-2 has no effect on human T cells (20) .
The inactivation of LDGF-SL 12 activity by 960C heat for 10 min and chymotrypsin attests to the protein nature of the factor. When the CM was treated at 560C for 30 min to inactivate retroviruses, the growth factor activity persisted. This suggests that stimulation of cell proliferation via virus interaction with viral receptors, as has been proposed (21), is not the mechanism of the cell proliferation observed here.
Thus, we show production of an autocrine growth factor, LDGF, from mouse lymphoma T-cell lines. It is present in all T-cell lymphomas tested. These findings suggest that continued production of this autostimulatory factor may be responsible for the malignant phenotype of these cells; in the case of AKR mouse lymphoma, as mentioned in the introduction, factor production may be induced by a specific integration of the lymphomagenic retroviruses in the genome of these cells. Since our cells have the phenotype of relatively immature thymocytes (6), we postulate that the normal counterpart of LDGF is produced by certain thymic progenitor cells to stimulate the active but highly controlled cell division that normally occurs in the thymic cortex.
